Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2008
11/04/2008US7446112 Modulators of muscarinic receptors
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446108 Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
11/04/2008CA2310458C Piperidine derivatives
10/2008
10/30/2008WO2008130600A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase
10/30/2008WO2008130481A1 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
10/30/2008WO2008129994A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008WO2008129624A1 Pyrazolopyridine-4-yl-pyrazolone derivative, addition salt thereof and phosphodiesterase inhibitor containing the same as active ingredient
10/30/2008WO2008129255A1 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer
10/30/2008WO2008129152A1 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof
10/30/2008WO2008129054A2 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008WO2008129007A1 Benzimidazoles with a hetero spiro-decane residue as npy-y5 antagonists
10/30/2008WO2008128968A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
10/30/2008WO2008128962A1 Tricyclic compounds as antibacterials
10/30/2008WO2008128942A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008WO2008128891A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008WO2008128436A1 Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
10/30/2008WO2008100635A8 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s
10/30/2008WO2008085942A3 Methods for preparing arene-bis(dicarboximide)-based semiconducting materials and related intermediates for preparing same
10/30/2008WO2008074752A3 Indolylmaleimide derivatives as kinase inhibitors
10/30/2008WO2008073311A3 Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
10/30/2008WO2008016648A3 Certain chemical entities, compositions and methods
10/30/2008WO2007103905A3 Prolyl hydroxylase inhibitors
10/30/2008US20080269485 Fluorinated dyes and their use in electrophoretic display devices
10/30/2008US20080269281 Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs
10/30/2008US20080269279 Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators
10/30/2008US20080269277 Pyrrolopyridine-2-Carboxylic Acid Hydrazides
10/30/2008US20080269275 Moderation of melanocyte stimulating hormone; psychological disorders; analgesics; anxiolytic agents; bipolar disorders;obesity; eating disorders; antidepressants
10/30/2008US20080269268 Substituted Phenylamino-Pyrimidines
10/30/2008US20080269250 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists
10/30/2008US20080269242 Central nervous system disorders in mammals; antidepressants; bipolar disorders; schizophrenia; autism; attention deficit disorders; post-traumatic stress disorders
10/30/2008US20080269241 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/30/2008US20080269230 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
10/30/2008US20080269227 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080269209 P 38 map kinase inhibitor; autoimmune diseases; antiinflammatory agents; cardovascular disorders; bone disorders; neurodegenerative diseases; antiproliferative agents
10/30/2008US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
10/30/2008US20080269192 Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds
10/30/2008US20080269169 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin
10/30/2008US20080269140 Conformationally Constrained Smac Mimetics and the Uses Thereof
10/30/2008US20080269131 Protein kinase B ; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; cancer and arthritis
10/30/2008US20080267887 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits
10/30/2008US20080267867 Imidazole, pyridine derivative silver complexes; nanofiber with radioactive transition metal, lanthanide, actinide; radiopharmaceutical peptide, polyamine, imaging and tumor treatment
10/30/2008US20080265746 Phenanthroline compound and organic light emitting device using the same
10/30/2008CA2684659A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008CA2682994A1 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008CA2682692A1 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
10/30/2008CA2682676A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
10/30/2008CA2682506A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008CA2678007A1 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof
10/29/2008EP1985313A1 Positron tomography method and positron-emitting compound to be used therein
10/29/2008EP1984376A2 Chemical compounds
10/29/2008EP1984366A1 3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
10/29/2008EP1984365A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/29/2008EP1984364A1 Heterobicyclic amide derivatives
10/29/2008EP1984363A1 Triazolopyridine compounds
10/29/2008EP1984353A1 Aurora kinase modulators and method of use
10/29/2008EP1984351A1 Compounds having 5-ht6 receptor affinity
10/29/2008EP1983990A1 A3 adenosine receptor allosteric modulators
10/29/2008EP1778686B1 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
10/29/2008EP1753764B1 Pyrrolopyridine derivatives
10/29/2008EP1653914A4 Oxime substituted imidazo-containing compounds
10/29/2008EP1648889B1 Isethionate salt of a selective cdk4 inhibitor
10/29/2008EP1506195B1 Non-nucleoside reverse transcriptase inhibitors
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008CN101296919A Benzo b thiophen derivative and process for production thereof
10/29/2008CN101296731A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101293867A Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
10/29/2008CN100428936C 抗病毒化合物 Antiviral compounds
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/28/2008US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
10/28/2008US7442710 Substituted phenyl methanones
10/28/2008US7442709 c-Kit proto-oncogene inhibitors(KIT, CD-117, stem cell or mast cell growth factor receptor); anticancer; better selectivity, potency, reduced toxicity, side effects; leukemias; angiogenesis; 3-{3-[(4-(Trifluoromethoxy)benzyl)oxy]phenyl}-N-(pyridine-3-ylmethyl)-3H-imidazo[4,5-b]pyridine-6-carboxamide
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008US7442701 Amino-heterocycles as VR-1 antagonists for treating pain
10/28/2008US7442698 Substituted heterocyclic compounds and methods of use
10/28/2008US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/23/2008WO2008127712A1 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
10/23/2008WO2008127678A1 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
10/23/2008WO2008127640A2 Substituted benzimidazoles
10/23/2008WO2008127615A1 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/23/2008WO2008127060A1 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126898A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008126123A2 Water-soluble coronene derivatives active as inhibitors of telomerase
10/23/2008WO2008126034A2 Oxazolidinone antibiotics
10/23/2008WO2008126024A2 Oxazolidinone antibiotic derivatives
10/23/2008WO2008125811A1 N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
10/23/2008WO2008125590A1 Biheteroaryl metal complexes as bleach catalysts
10/23/2008WO2008125578A2 A method for the preparation of mirtazapine
10/23/2008WO2008125577A1 A method for the preparation of an enantiomerically pure benzazepine
1 ... 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 ... 646